UNSPSC 51183204: Tolrestat

This classification denotes an aldose reductase inhibitor with the molecular formula C16H14F3NO3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 0T93LG5NMK, chemically known as glycine, n-((6-methoxy-5-(trifluoromethyl)-1-naphthalenyl)thioxomethyl)-n-methyl- but more generally known as tolrestat, which bears US NIH Compound Identifier 53359. European Medicines Agency schedules Tolrestat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11179MIG.

UNSPSC 51183204 Tolrestat is a Commodity code covering specific pharmaceutical products supplied through state and local cooperative purchasing agreements. State and local governments procure under this code primarily through multistate cooperative purchasing alliances that aggregate demand across participating jurisdictions and authorized pharmaceutical wholesalers, consolidating purchases of generic and branded pharmaceuticals to achieve volume pricing and standardized supply chain management across health departments, corrections systems, mental health facilities, and other state and local healthcare operations.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, is the primary recent issuer under this code. MMCAP issued an RFP in January 2026 (Solicitation S1070000015802) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities, including Oregon, with proposals due March 26, 2026. Vendors must supply products exclusively through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—and certify compliance with current Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act (DSCSA). The RFP weights price competitiveness at 75 percent of evaluation, fixed pricing at 10 percent, and compliance with administrative requirements, EDI capability, and agreement to a 3 percent administrative fee at 5 percent each. The contract term is two years for new vendors, with optional extensions at MMCAP's discretion; incumbent responder amendments align with existing agreement expiration through June 30, 2028. All products must be available in the marketplace by May 15, 2026, when awarded vendors will be provided to authorized wholesalers with resulting agreements effective July 1, 2026.